$CADX Recent News U.S. stock benchmarks rally fr
Post# of 89342
Posted On: 11/17/2013 8:38:08 PM
$CADX Recent News
U.S. stock benchmarks rally from obvious support 9:51 a.m. June 10, 2013 - Michael Ashbaugh
Cadence falls on analyst downgrade 2:40 p.m. Aug. 30, 2012 - Val Brickates Kennedy
Stocks to watch Wednesday: AT&T, AES, Deere 6:54 a.m. Nov. 23, 2011 - MarketWatch
Cadence Pharmaceuticals down 5.3% 12:01 p.m. Nov. 15, 2011 - David B. Wilkerson
Cadence Pharma plans to sell $75 mln in stock 8:05 a.m. Nov. 14, 2011 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:44 p.m. March 4, 2011 - Kate Gibson
Wednesday’s biggest gaining and declining stocks 3:32 p.m. Nov. 3, 2010 - Kate Gibson
Drug indexes flat as Lundbeck slides 12:09 p.m. Nov. 3, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:52 p.m. April 19, 2010 - MarketWatch
Cadence jumps, Lilly slips in afternoon trading 12:51 p.m. April 19, 2010 - Val Brickates Kennedy
In focus: At the highs 6:42 p.m. Nov. 11, 2009 - Lawrence G. McMillan
Cadence Pharma starts at buy at Pacific Growth 10:57 a.m. Dec. 4, 2006 - Leslie Wines
Merrill sets Cadence Pharma price target at $16 9:21 a.m. Dec. 4, 2006 - Tomi Kilgore
Cadence Pharma started at buy at Merrill Lynch 9:21 a.m. Dec. 4, 2006 - Tomi Kilgore
Cadence Pharma IPO rises after price cut 10:39 a.m. Oct. 25, 2006 - Steve Gelsi
Cadence Pharma prices IPO of 6M shares at $9 each 7:56 a.m. Oct. 25, 2006 - Thomas Middleton
Cadence: Best Case Outcome On Ofirmev Patent Litigation 9:35 a.m. Nov. 15, 2013 - Seeking Alpha
Cadence Pharmaceuticals Announces Favorable Court Ruling In OFIRMEV Patent Litigation 5:58 p.m. Nov. 14, 2013 - benzinga.com
Cadence Pharma Reports In-Line Loss, Beats Rev - Analyst Blog 11:50 a.m. Nov. 7, 2013 - Zacks.com
10-Q: CADENCE PHARMACEUTICALS INC 4:41 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cadence Pharmaceuticals: Ofirmev Launch A Spectacular Success, But Investors Focused On Patent Litigation 1:42 p.m. Nov. 6, 2013 - Seeking Alpha
Cadence Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 8:33 p.m. Nov. 5, 2013 - Seeking Alpha
Cadence Pharma's Ofirmev Gets Black Box - Analyst Blog 11:10 a.m. Oct. 21, 2013 - Zacks.com
Cadence: Comments On Patent Office Re-Examination Of Key Cadence Patent 1:46 p.m. Aug. 16, 2013 - Seeking Alpha
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent, Says Patents On OFIRMEV Are Valid Until Final Ruling 3:22 p.m. Aug. 15, 2013 - benzinga.com
Cadence: Ofirmev Sales Are Very Strong; Patent Decision Could Come By Year-End 6:10 p.m. Aug. 2, 2013 - Seeking Alpha
10-Q: CADENCE PHARMACEUTICALS INC 3:15 p.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Wider Loss at CADX in Q2 - Analyst Blog 11:58 a.m. Aug. 1, 2013 - Zacks.com
Cadence Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript 7:35 p.m. July 31, 2013 - Seeking Alpha
Wider 2Q Loss at ArQule - Analyst Blog 4:00 p.m. July 31, 2013 - Zacks.com
Cadence Pharmaceuticals Inc. (CADX) Management Discusses Q2 2013 Results (Webcast) 3:34 p.m. July 31, 2013 - Seeking Alpha
Narrower-Than-Expected Loss at BioMarin - Analyst Blog 3:45 p.m. July 26, 2013 - Zacks.com
Earnings Beat at Warner Chilcott - Analyst Blog 12:10 p.m. July 25, 2013 - Zacks.com
Glaxo Revs Up, Earnings Down - Analyst Blog 11:10 a.m. July 25, 2013 - Zacks.com
Pipeline Progress at XOMA - Analyst Blog 4:20 p.m. July 24, 2013 - Zacks.com
TTHI, Eli Lilly Ink Deal - Analyst Blog 4:00 p.m. July 24, 2013 - Zacks.com
Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation 6:54 p.m. Nov. 14, 2013 - PR Newswire
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback 3:00 p.m. Nov. 8, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:00 p.m. Nov. 5, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013 3:00 p.m. Oct. 29, 2013 - PR Newswire
Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013 3:00 p.m. Sept. 4, 2013 - PR Newswire
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent 4:17 p.m. Aug. 15, 2013 - PR Newswire
Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors 7:30 a.m. Aug. 15, 2013 - PR Newswire
Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013 4:45 p.m. Aug. 6, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results 3:00 p.m. July 31, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013 3:00 p.m. July 24, 2013 - PR Newswire
Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013 5:00 p.m. July 2, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ANGI, CADX, FMER and MKTG 7:33 a.m. June 24, 2013 - ACCESSWIRE
Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013 3:00 p.m. May 8, 2013 - PR Newswire
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results 3:00 p.m. May 2, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013 3:00 p.m. April 25, 2013 - PR Newswire
Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors 3:00 p.m. March 14, 2013 - PR Newswire
Cadence Pharmaceuticals Announces the Availability of OFIRMEV® (acetaminophen) Injection through the VA National Formulary 7:00 a.m. March 12, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results 7:30 a.m. March 7, 2013 - PR Newswire
Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV? (acetaminophen) Injection 8:23 p.m. March 6, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013 4:15 p.m. Feb. 28, 2013 - PR Newswire
U.S. stock benchmarks rally from obvious support 9:51 a.m. June 10, 2013 - Michael Ashbaugh
Cadence falls on analyst downgrade 2:40 p.m. Aug. 30, 2012 - Val Brickates Kennedy
Stocks to watch Wednesday: AT&T, AES, Deere 6:54 a.m. Nov. 23, 2011 - MarketWatch
Cadence Pharmaceuticals down 5.3% 12:01 p.m. Nov. 15, 2011 - David B. Wilkerson
Cadence Pharma plans to sell $75 mln in stock 8:05 a.m. Nov. 14, 2011 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:44 p.m. March 4, 2011 - Kate Gibson
Wednesday’s biggest gaining and declining stocks 3:32 p.m. Nov. 3, 2010 - Kate Gibson
Drug indexes flat as Lundbeck slides 12:09 p.m. Nov. 3, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:52 p.m. April 19, 2010 - MarketWatch
Cadence jumps, Lilly slips in afternoon trading 12:51 p.m. April 19, 2010 - Val Brickates Kennedy
In focus: At the highs 6:42 p.m. Nov. 11, 2009 - Lawrence G. McMillan
Cadence Pharma starts at buy at Pacific Growth 10:57 a.m. Dec. 4, 2006 - Leslie Wines
Merrill sets Cadence Pharma price target at $16 9:21 a.m. Dec. 4, 2006 - Tomi Kilgore
Cadence Pharma started at buy at Merrill Lynch 9:21 a.m. Dec. 4, 2006 - Tomi Kilgore
Cadence Pharma IPO rises after price cut 10:39 a.m. Oct. 25, 2006 - Steve Gelsi
Cadence Pharma prices IPO of 6M shares at $9 each 7:56 a.m. Oct. 25, 2006 - Thomas Middleton
Cadence: Best Case Outcome On Ofirmev Patent Litigation 9:35 a.m. Nov. 15, 2013 - Seeking Alpha
Cadence Pharmaceuticals Announces Favorable Court Ruling In OFIRMEV Patent Litigation 5:58 p.m. Nov. 14, 2013 - benzinga.com
Cadence Pharma Reports In-Line Loss, Beats Rev - Analyst Blog 11:50 a.m. Nov. 7, 2013 - Zacks.com
10-Q: CADENCE PHARMACEUTICALS INC 4:41 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cadence Pharmaceuticals: Ofirmev Launch A Spectacular Success, But Investors Focused On Patent Litigation 1:42 p.m. Nov. 6, 2013 - Seeking Alpha
Cadence Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 8:33 p.m. Nov. 5, 2013 - Seeking Alpha
Cadence Pharma's Ofirmev Gets Black Box - Analyst Blog 11:10 a.m. Oct. 21, 2013 - Zacks.com
Cadence: Comments On Patent Office Re-Examination Of Key Cadence Patent 1:46 p.m. Aug. 16, 2013 - Seeking Alpha
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent, Says Patents On OFIRMEV Are Valid Until Final Ruling 3:22 p.m. Aug. 15, 2013 - benzinga.com
Cadence: Ofirmev Sales Are Very Strong; Patent Decision Could Come By Year-End 6:10 p.m. Aug. 2, 2013 - Seeking Alpha
10-Q: CADENCE PHARMACEUTICALS INC 3:15 p.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Wider Loss at CADX in Q2 - Analyst Blog 11:58 a.m. Aug. 1, 2013 - Zacks.com
Cadence Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript 7:35 p.m. July 31, 2013 - Seeking Alpha
Wider 2Q Loss at ArQule - Analyst Blog 4:00 p.m. July 31, 2013 - Zacks.com
Cadence Pharmaceuticals Inc. (CADX) Management Discusses Q2 2013 Results (Webcast) 3:34 p.m. July 31, 2013 - Seeking Alpha
Narrower-Than-Expected Loss at BioMarin - Analyst Blog 3:45 p.m. July 26, 2013 - Zacks.com
Earnings Beat at Warner Chilcott - Analyst Blog 12:10 p.m. July 25, 2013 - Zacks.com
Glaxo Revs Up, Earnings Down - Analyst Blog 11:10 a.m. July 25, 2013 - Zacks.com
Pipeline Progress at XOMA - Analyst Blog 4:20 p.m. July 24, 2013 - Zacks.com
TTHI, Eli Lilly Ink Deal - Analyst Blog 4:00 p.m. July 24, 2013 - Zacks.com
Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation 6:54 p.m. Nov. 14, 2013 - PR Newswire
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback 3:00 p.m. Nov. 8, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:00 p.m. Nov. 5, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013 3:00 p.m. Oct. 29, 2013 - PR Newswire
Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013 3:00 p.m. Sept. 4, 2013 - PR Newswire
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent 4:17 p.m. Aug. 15, 2013 - PR Newswire
Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors 7:30 a.m. Aug. 15, 2013 - PR Newswire
Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013 4:45 p.m. Aug. 6, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results 3:00 p.m. July 31, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013 3:00 p.m. July 24, 2013 - PR Newswire
Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013 5:00 p.m. July 2, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ANGI, CADX, FMER and MKTG 7:33 a.m. June 24, 2013 - ACCESSWIRE
Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013 3:00 p.m. May 8, 2013 - PR Newswire
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results 3:00 p.m. May 2, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013 3:00 p.m. April 25, 2013 - PR Newswire
Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors 3:00 p.m. March 14, 2013 - PR Newswire
Cadence Pharmaceuticals Announces the Availability of OFIRMEV® (acetaminophen) Injection through the VA National Formulary 7:00 a.m. March 12, 2013 - PR Newswire
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results 7:30 a.m. March 7, 2013 - PR Newswire
Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV? (acetaminophen) Injection 8:23 p.m. March 6, 2013 - PR Newswire
Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013 4:15 p.m. Feb. 28, 2013 - PR Newswire
(0)
(0)